ISSN: 2161-0681

Journal de pathologie clinique et expérimentale

Accès libre

Notre groupe organise plus de 3 000 séries de conférences Événements chaque année aux États-Unis, en Europe et en Europe. Asie avec le soutien de 1 000 autres Sociétés scientifiques et publie plus de 700 Open Access Revues qui contiennent plus de 50 000 personnalités éminentes, des scientifiques réputés en tant que membres du comité de rédaction.

Les revues en libre accès gagnent plus de lecteurs et de citations
700 revues et 15 000 000 de lecteurs Chaque revue attire plus de 25 000 lecteurs

Indexé dans
  • Index Copernic
  • Google Scholar
  • Sherpa Roméo
  • Ouvrir la porte J
  • JournalSeek de génamique
  • JournalTOC
  • Annuaire des périodiques d'Ulrich
  • Recherche de référence
  • Université Hamdard
  • EBSCO AZ
  • OCLC-WorldCat
  • Publons
  • Fondation genevoise pour l'enseignement et la recherche médicale
  • Euro Pub
  • ICMJE
Partager cette page

Abstrait

Stromal SPARC Expression Patterns and Diagnostic Potential in Mucocutaneous Squamous Cell Carcinoma

Paral KM and Cipriani NA

Background: SPARC (secreted protein acidic and rich in cysteine) is a key player in the stromal remodeling associated with invasive carcinomas, and its detection by immunohistochemistry may prove diagnostically useful in detecting invasion. The present study explores stromal SPARC expression patterns in invasive mucocutaneous squamous cell carcinoma (SCC). The patterns are then compared to those of SMA, a relatively well-studied but imperfect marker of cancer-associated stroma.

Methods: Nineteen cases of infiltrating keratinizing SCCs from skin and mucous membranes were assessed semi-quantitatively for immunoreactivity with anti-SMA or anti-SPARC antibodies in tumor-free and tumor-associated stroma.

Results: All cases of invasive SCCs (n=19) demonstrated stromal expression of both SMA and SPARC. However, SPARC showed more diffuse reactivity than SMA, with SPARC demonstrating a mean percentage reactivity range of 50-75%, versus 25-50% for SMA. In tumor-free stroma, SMA was negative in all cases, whereas SPARC was positive in up to 5% of dendritic stromal cells in more than half of the cases.

Conclusions: Stromal SPARC overexpression is a consistent finding in invasive SCC, and SPARC is more sensitive but less specific for cancer-associated stroma than SMA. While H&E examination remains the gold standard for determining whether invasion is present, stromal SPARC expression patterns may serve as an adjunct to the histopathologic impression.